Active — Not RecruitingNot Applicable

Intraoperative Costs and Patient Perceptions in Sacrocolpopexy for Prolapse

United States80 participantsStarted 2019-12-10

Plain-language summary

Robotic sacrocolpopexy (a procedure for female pelvic organ prolapse) has been demonstrated to have equivalent surgical outcomes to open abdominal sacrocolpopexy and has been previously deemed more cost effective due to the longer hospital course following open procedures. The total cost of these procedures, including all costs of hospitalization as well as costs associated with the 30 days following surgery have previously been evaluated by the investigators. However, previous research is lacking in both the specific cost components that contribute to intraoperative cost of surgery as well as the patient perceived outcomes following these two procedures. This project aims to evaluate the marginal costs of surgery and to survey sacrocolpopexy patients to evaluate their satisfaction with outcomes and surgical scars.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women ≥ 18 years of age * Undergoing abdominal or robotic sacrocolpopexy with or without posterior vaginal repairs * Willing and able to provide signed informed research consent * Concurrent and prior hysterectomy Exclusion Criteria: * Repeat sacrocolpopexy * Concurrent sling procedure * Concurrent Pouch of Douglas repairs * Concurrent anterior vaginal wall repairs

What they're measuring

Intraoperative cost of surgery

Timeframe: SIx weeks postop

Patient Scar Assessment

Timeframe: Six weeks postop

Trial details

NCT IDNCT04179955

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Pelvic Organ Prolapse trials